Average Premiums for Health Care Coverage Stable in 2016
Family premium 3 percent higher in 2016 than 2015; no change in share of firms offering health benefits
Testosterone Seems Safe for Hypogonadal Prostate CA Patients
Testosterone therapy seems oncologically safe after treatment or for those on active surveillance
Tension-Free Vaginal Tape-Obturator Has Lasting Benefit
After 10 years, objective and subjective cure rates were 69 and 64 percent, respectively
Recommendations Developed for Cost-Effectiveness Analyses
Concept of reference case, set of standard practices that all analyses should follow is recommended
Outlook Good for Localized Prostate CA, Despite Tx Chosen
Survival rates high for active surveillance, radiation, or prostatectomy
Potential Mechanism ID’d for Impact of Parity on Pelvic Floor
Parity tied to increased fiber length in more proximal coccygeus, iliococcygeus pelvic floor muscles
Value-Driven Outcomes Tool Can Cut Health Care Costs
Highest variability in costs identified for post-op infection and sepsis, lowest for organ transplant
New Anticancer Drugs Up Costs and Life Expectancy Considerably
Lifetime costs up $72,000, life expectancy up 13 months with new drug use in breast cancer
Lean Processes Can Cut Wait Times at VA Hospitals
Drop in mean patient wait times for elective general surgical procedures; increase in operating volume
PSA Failure Predicts Death in Men With No, Minimal Comorbidity
Findings among men with localized intermediate- and high-risk prostate cancer
